ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma? Dr. Gareth Morgan - 100038

Spotlight
Video

ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma? Dr. Gareth Morgan

patientpower has 2418 videos Subscribe Here

Loading........
Description: Where do things stand now with personalizing myeloma therapy to a patient’s genetic profile? At the American Society of Hematology (ASH) 2017 conference in Atlanta, Esther Schorr speaks with Dr. Gareth Morgan, Director of the UAMS Myeloma Institute, about new oncogenes in myeloma. They also discuss the importance of testing at the time of myeloma diagnosis to set a treatment plan. Watch for this top myeloma expert’s take on the latest myeloma research.
Shared By : patientpower
Posted on : 12/22/17
Added : 2 months ago
Category : Multiple Myeloma